Charles D. Ebert
Impact in
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Dermatology top 5%
- Dermatology and Skin Diseases
- Contact Dermatitis and Allergies
Papers in
-
- Biochemical and Structural Characterization 1
-
- Advancements in Transdermal Drug Delivery 3
- Advanced Drug Delivery Systems 2
- Drug Solubulity and Delivery Systems 1
- Co-authors
- Sung Wan Kim (3 shared papers)Bret Berner (2 shared papers)Gerard C. Mazzenga (2 shared papers)Shuji Sato (1 shared paper)Jie Zhang (1 shared paper)Theodore H. Stanley (1 shared paper)Jan Feijén (1 shared paper)Wim E. Hennink (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (3 papers)Thrombosis Research (2 papers)Pharmaceutical Research (1 paper)Annals of the New York Academy of Sciences (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- United StatesNetherlandsSouth Korea
In The Last Decade
Charles D. Ebert
8 papers receiving 414 citations
Peers
Comparison fields: 5 of 81
- Pharmaceutical Science 246
- Dermatology 97
- Surfaces, Coatings and Films 44
- Biomaterials 67
- Cell Biology 47
Countries citing papers authored by Charles D. Ebert
This map shows the geographic impact of Charles D. Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles D. Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles D. Ebert more than expected).
Fields of papers citing papers by Charles D. Ebert
This network shows the impact of papers produced by Charles D. Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles D. Ebert. The network helps show where Charles D. Ebert may publish in the future.
Co-authors
The 13 scholars most cited alongside Charles D. Ebert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 149 | |
| 2 | 1983 | 65 | |
| 3 | 1982 | 63 | |
| 4 | 1994 | 51 | |
| 5 | 1983 | 48 | |
| 6 | 1989 | 41 | |
| 7 | 1999 | 21 | |
| 8 | 1983 | 13 |
About Charles D. Ebert
Charles D. Ebert is a scholar working on Molecular Biology, Pharmaceutical Science, Dermatology, Cell Biology and Biomedical Engineering, having authored 8 papers that have together received 451 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (3 papers), Dermatology and Skin Diseases (2 papers), Advanced Drug Delivery Systems (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Drug Solubulity and Delivery Systems (1 paper), Nanoplatforms for cancer theranostics (1 paper), Biochemical and Structural Characterization (1 paper) and Bee Products Chemical Analysis (1 paper). The work is most often cited by research in Pharmaceutical Science (246 citations), Dermatology (97 citations), Surfaces, Coatings and Films (44 citations), Biomaterials (67 citations) and Cell Biology (47 citations). Charles D. Ebert has collaborated with scholars based in United States, Netherlands and South Korea. Frequent co-authors include Sung Wan Kim, Bret Berner, Gerard C. Mazzenga, Shuji Sato, Jie Zhang, Theodore H. Stanley, Jan Feijén, Wim E. Hennink, Jindřich Kopeček and Vladimir G. Omelyanenko. Their work appears in journals such as Journal of Pharmaceutical Sciences, Thrombosis Research, Pharmaceutical Research, Annals of the New York Academy of Sciences and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.